Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transmural collaborative care and duloxetine for major depressive disorder with subchronic or chronic pain
2009-010188-18Phase 4Active
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of duloxetine in major depressive disorder (MDD) (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: Depression response. Started Jun 2010; status: active.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2009-010188-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010188-18.